Fruit Extract Modulated Antioxidant Gene Expression, Prevented Oxidative Stress and Ameliorated Kidney Dysfunction in Isoprenaline Administered Rats

Overview

Journal Biochem Biophys Rep

Specialty Biochemistry

Date 2021 May 27

PMID 34041370

Citations 6

Authors

Saima Selim

Noushin Akter

Shariful Islam Nayan

Faizul Islam Chowdhury

Nadia Saffoon

Ferdous Khan

Khondoker Shahin Ahmed

Md Iqbal Ahmed

Mohammad Maqsud Hossain

Md Ashraful Alam

Affiliations

Soon will be listed here.

Abstract

This study evaluated the effect of fruit extract against isoprenaline (ISO) induced renal damage in rats. This investigation showed that ISO administration in rats increased the level oxidative stress biomarkers such as malondialdehyde (MDA), nitric oxide (NO), advanced protein oxidation product (APOP) in kidneys followed by a decrease in antioxidant enzymes functions. fruit extract, which is rich in strong antioxidants, also reduced the MDA, NO and APOP level in kidney of ISO administered rats. Inflammation and necrosis was also visible in kidney section of ISO administered rats which was significantly prevented by atenolol and fruit extract. Moreover, atenolol and fruit extract also modulated the genes expressions related to inflammation and oxidative stress in kidneys. The beneficial effects could be attributed to the presence of a number of phenolic antioxidants. This study suggests that fruit extract may prevent kidney dysfunction in ISO administered rats, probably by preventing oxidative stress and inflammation.

Citing Articles

Evaluation of Xanthine Oxidase Inhibitors Febuxostat and Allopurinol on Kidney Dysfunction and Histological Damage in Two-Kidney, One-Clip (2K1C) Rats.

Shuvo A, Alimullah M, Jahan I, Mitu K, Rahman M, Akramuddaula K Scientifica (Cairo). 2025; 2025:7932075.

PMID: 39886537 PMC: 11779995. DOI: 10.1155/sci5/7932075.

Modeling of Isoproterenol-Induced Chronic Heart Failure in 24-Month-Old Rats.

Rebrova T, Korepanov V, Stepanov I, Afanasiev S Bull Exp Biol Med. 2024; 178(1):30-33.

PMID: 39572489 DOI: 10.1007/s10517-024-06277-8.

Exploring the Role of Phenolic Compounds in Chronic Kidney Disease: A Systematic Review.

Baptista F, Paie-Ribeiro J, Almeida M, Barros A Molecules. 2024; 29(11).

PMID: 38893451 PMC: 11173950. DOI: 10.3390/molecules29112576.

Protective effects of l-carnitine on isoprenaline -induced heart and kidney dysfunctions: Modulation of inflammation and oxidative stress-related gene expression in rats.

Chisty T, Sarif S, Jahan I, Ismail I, Chowdhury F, Siddiqua S Heliyon. 2024; 10(3):e25057.

PMID: 38322874 PMC: 10845729. DOI: 10.1016/j.heliyon.2024.e25057.

Implication of MAPK, Lipocalin-2, and Fas in the protective action of liposomal resveratrol against isoproterenol-induced kidney injury.

Alhusaini A, Alshehri S, Sarawi W, Alghibiwi H, Alturaif S, Al Khbiah R Saudi Pharm J. 2024; 32(1):101907.

PMID: 38178854 PMC: 10764257. DOI: 10.1016/j.jsps.2023.101907.

References

Zoja C, Benigni A, Remuzzi G . The Nrf2 pathway in the progression of renal disease. Nephrol Dial Transplant. 2013; 29 Suppl 1:i19-i24. DOI: 10.1093/ndt/gft224. View

Singh S, Shrivastava A, Jyotshna , Chaturvedi U, Singh S, Shanker K . A mechanism-based pharmacological evaluation of efficacy of Flacourtia indica in management of dyslipidemia and oxidative stress in hyperlipidemic rats. J Basic Clin Physiol Pharmacol. 2015; 27(2):121-9. DOI: 10.1515/jbcpp-2015-0017. View

Zamora R, Vodovotz Y, Billiar T . Inducible nitric oxide synthase and inflammatory diseases. Mol Med. 2000; 6(5):347-73. PMC: 1949959. View

Yamawaki K, Kanda H, Shimazaki R . Nrf2 activator for the treatment of kidney diseases. Toxicol Appl Pharmacol. 2018; 360:30-37. DOI: 10.1016/j.taap.2018.09.030. View

Kulathunga M, Wijayawardena M, Naidu R, Wijeratne A . Chronic kidney disease of unknown aetiology in Sri Lanka and the exposure to environmental chemicals: a review of literature. Environ Geochem Health. 2019; 41(5):2329-2338. DOI: 10.1007/s10653-019-00264-z. View

Balogun E, Hoque M, Gong P, Killeen E, Green C, Foresti R . Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J. 2003; 371(Pt 3):887-95. PMC: 1223348. DOI: 10.1042/BJ20021619. View

de Silva M . Drinking water and chronic kidney disease of unknown aetiology in Anuradhapura, Sri Lanka. Anthropol Med. 2018; 26(3):311-327. DOI: 10.1080/13648470.2018.1446822. View

Vijaya Padma V, Poornima P, Prakash C, Bhavani R . Oral treatment with gallic acid and quercetin alleviates lindane-induced cardiotoxicity in rats. Can J Physiol Pharmacol. 2013; 91(2):134-40. DOI: 10.1139/cjpp-2012-0279. View

Nuhu F, Bhandari S . Oxidative Stress and Cardiovascular Complications in Chronic Kidney Disease, the Impact of Anaemia. Pharmaceuticals (Basel). 2018; 11(4). PMC: 6316624. DOI: 10.3390/ph11040103. View

10.

Moniri N, Daaka Y . Agonist-stimulated reactive oxygen species formation regulates beta2-adrenergic receptor signal transduction. Biochem Pharmacol. 2007; 74(1):64-73. DOI: 10.1016/j.bcp.2007.03.016. View

11.

Goncalves G, Cenedeze M, Feitoza C, Wang P, Bertocchi A, Damiao M . The role of heme oxygenase 1 in rapamycin-induced renal dysfunction after ischemia and reperfusion injury. Kidney Int. 2006; 70(10):1742-9. DOI: 10.1038/sj.ki.5001893. View

12.

Impellizzeri D, Esposito E, Attley J, Cuzzocrea S . Targeting inflammation: new therapeutic approaches in chronic kidney disease (CKD). Pharmacol Res. 2014; 81:91-102. DOI: 10.1016/j.phrs.2014.02.007. View

13.

Ulla A, Mohamed M, Sikder B, Rahman A, Sumi F, Hossain M . Coenzyme Q10 prevents oxidative stress and fibrosis in isoprenaline induced cardiac remodeling in aged rats. BMC Pharmacol Toxicol. 2017; 18(1):29. PMC: 5399319. DOI: 10.1186/s40360-017-0136-7. View

14.

Odobasic D, Kitching A, Semple T, Holdsworth S . Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis. J Am Soc Nephrol. 2007; 18(3):760-70. DOI: 10.1681/ASN.2006040375. View

15.

Wang Y, Niu M, Yin S, Zhang F, Shi R . Nephroprotective effects of nebivolol in 2K1C rats through regulation of the kidney ROS-ADMA-NO pathway. Pharmacol Rep. 2018; 70(5):917-929. DOI: 10.1016/j.pharep.2018.04.004. View

16.

Biernacka A, Dobaczewski M, Frangogiannis N . TGF-β signaling in fibrosis. Growth Factors. 2011; 29(5):196-202. PMC: 4408550. DOI: 10.3109/08977194.2011.595714. View

17.

Tonelli M, Agarwal S, Cass A, Garcia G, Jha V, Naicker S . How to advocate for the inclusion of chronic kidney disease in a national noncommunicable chronic disease program. Kidney Int. 2013; 85(6):1269-74. DOI: 10.1038/ki.2012.488. View

18.

Duni A, Liakopoulos V, Rapsomanikis K, Dounousi E . Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden?. Oxid Med Cell Longev. 2018; 2017:9036450. PMC: 5733207. DOI: 10.1155/2017/9036450. View

19.

Cao Y, Hu J, Sui J, Jiang L, Cong Y, Ren G . Quercetin is able to alleviate TGF-β-induced fibrosis in renal tubular epithelial cells by suppressing miR-21. Exp Ther Med. 2018; 16(3):2442-2448. PMC: 6122524. DOI: 10.3892/etm.2018.6489. View

20.

Dhalla N, Temsah R, Netticadan T . Role of oxidative stress in cardiovascular diseases. J Hypertens. 2000; 18(6):655-73. DOI: 10.1097/00004872-200018060-00002. View